Hypertrophic Cardiomyopathy in Dogs (Hypertrophic Cardiomyopathy, HCM)
- Occurrence: common
- Location of disease: Chest
When to visit the vet?
Non-urgent see a veterinarian within 2–3 days
If the condition worsens / symptoms persist, consult a veterinarian.
Definition
Hypertrophic Cardiomyopathy (HCM) is a heart disease in dogs characterized by a thickening of the heart muscle, especially of the left ventricle, which can impair the normal function of the heart.
The most important facts at a glance
Hypertrophic cardiomyopathy (HCM) in dogs is a heart disease in which the heart muscle is thickened, impairing the heart’s ability to pump blood efficiently. This thickening makes the heart chambers stiffer, making it harder for the heart to fill with blood during the relaxation phase. The causes of HCM are not fully understood, but genetic factors play a major role. Some dog breeds have an inherited predisposition, while in other cases the cause is unknown. Symptoms include reduced exercise tolerance, Dyspnea (labored breathing), and Cough. Diagnosis is made through clinical examination, cardiac ultrasound, and sometimes genetic testing. Treatment aims to relieve symptoms and improve quality of life, as a cure is not possible. Medications such as a beta blocker and diuretics may be used. The prognosis varies depending on disease severity and response to treatment. Prevention is limited, but responsible breeding practices and regular veterinary check-ups can help detect early signs. Research focuses on genetic studies and new treatment methods, including investigating nutrition and regenerative medicine.
Causes
HCM in dogs is a condition that impairs the heart’s ability to pump blood efficiently. The thickening of the heart muscle causes the ventricles to become stiffer, making it difficult for the heart to fill with blood during the diastolic phase, i.e., the relaxation phase of the heart muscle. This thickening can also affect the heart valves and the blood vessels that supply the heart itself.
The exact causes of HCM in dogs are not fully understood, but genetic factors are believed to play a major role. In some dog breeds, as in cats, there is an inherited predisposition to developing this condition. In other cases, the cause may be idiopathic, meaning it is unknown.
In addition to genetic factors, environmental factors and secondary diseases could contribute to the development of HCM. Some studies suggest that hormonal disorders, such as hyperthyroidism, may also be associated with heart muscle thickening. However, this is less common in dogs than in cats.
Symptoms
Dogs with HCM can show a range of symptoms that are often subtle and hard to recognize. Common symptoms include Dyspnea (labored breathing), Cough, reduced exercise tolerance, or sudden weakness. These symptoms result from the heart’s reduced ability to pump blood efficiently, which can lead to fluid accumulation in the lungs or chest cavity.
In some cases, Cardiac arrhythmia can occur, presenting as an irregular heartbeat. These can be serious and may lead to syncope (brief loss of consciousness).
Another possible, but less common, symptom is ascites—fluid buildup in the abdomen—which can be caused by congestion in the venous circulation. Some dogs also show signs of Restlessness or behavioral changes, which may indicate discomfort or Pain.
Diagnosis
Diagnosing hypertrophic cardiomyopathy in dogs requires a combination of clinical examination, imaging, and sometimes genetic testing. The vet will first take a thorough medical history and examine the dog for symptoms that could indicate heart problems.
An important diagnostic tool is echocardiography (cardiac ultrasound), which provides a detailed view of the heart chambers and valves. Echocardiography allows the vet to assess thickening of the heart muscle as well as heart function.
In addition, chest X-rays may be taken to detect signs of fluid buildup or changes in heart size. An ECG (electrocardiogram) can be used to identify Cardiac arrhythmia.
In some cases, a genetic test may be considered, especially if an inherited form of HCM is suspected. These tests can help identify genetic mutations associated with the disease.
Therapy
The treatment of HCM in dogs aims to alleviate the symptoms and improve the animal’s quality of life, as a cure for the disease is not possible. Medications can be used to support heart function and control symptoms.
A beta blocker or calcium channel blocker may be prescribed to lower heart rate and regulate blood pressure, which can reduce strain on the heart. Diuretics can help remove excess fluid from the body, reducing Dyspnea (labored breathing) and Swelling.
ACE inhibitor can also be useful to reduce strain on the heart and dilate blood vessels. In some cases, treatment for Cardiac arrhythmia may be necessary, which can be achieved with antiarrhythmic medications.
It’s important that treatment is tailored to the individual dog, as responses to medication can vary. Regular check-ups with the vet are essential to monitor disease progression and adjust therapy accordingly.
Prognosis and follow-up care
The prognosis for dogs with HCM varies greatly and depends on several factors, including the severity of the disease, response to treatment, and the presence of concurrent conditions. In some cases, the disease can remain stable for years, while in others it may progress quickly.
A dog with a mild form of HCM that responds well to treatment can have a relatively normal quality of life. However, in more severe forms of the disease—especially if complications such as Cardiac arrhythmia or heart failure occur—the prognosis is less favorable.
It is important to always keep the animal’s quality of life in mind and work closely with the veterinarian to ensure the best possible care. In some cases, a serious deterioration of the disease may require a difficult decision about euthanasia to spare the animal unnecessary suffering.
Prevention
Because the exact cause of HCM in dogs is often unknown, specific prevention strategies are limited. In breeds predisposed to HCM, responsible breeding practices can help reduce the risk of passing on genetic predispositions. This includes genetic screening of breeding animals and excluding animals with known genetic mutations from breeding.
Regular veterinary check-ups are crucial to detect early signs of heart problems. A timely diagnosis can help slow disease progression and improve the dog’s quality of life. Owners should watch for possible symptoms and consult a vet immediately if heart problems are suspected.
A balanced diet and regular exercise can also contribute to general heart health, although they cannot directly prevent the development of HCM. It is important to keep the dog fit and at a healthy weight to minimize the strain on the heart.
Outlook on current research
Hypertrophic cardiomyopathy (HCM) is a complex condition that occurs less often in dogs than in cats, but is no less significant. Current research focuses on better understanding the genetic basis of this disease in dogs. Genetic studies have shown that HCM often runs in families, meaning there is an inherited component. Researchers are working to identify specific genetic markers associated with the disease to enable earlier and more accurate diagnoses.
Another research focus is the development and improvement of diagnostic techniques. Early detection of HCM is crucial to slow disease progression and improve the dog’s quality of life. Current studies are examining the effectiveness of advanced imaging methods such as echocardiography and magnetic resonance imaging (MRI) for detailed assessment of heart structure and function.
Treatment options for HCM in dogs are also at the center of research. While current treatments aim to alleviate symptoms and slow the progression of the disease, scientists are investigating new drug approaches that could directly target the underlying causes of the disease. Clinical trials are testing the effectiveness of new drugs that may slow heart muscle growth or improve heart function.
In addition to drug treatment, the role of nutrition in the treatment of HCM is also being investigated. Some studies suggest that certain diets or supplements may affect the risk or progression of the disease. Researchers are evaluating the effects of omega-3 fatty acids and other heart-supporting nutrients on dogs with HCM to develop more precise nutritional guidelines.
A promising area of research is regenerative medicine. Scientists are investigating the possibility of using stem cells to repair or regenerate damaged heart tissue. Although this research is still in its early stages, it could offer new treatment approaches for dogs with HCM in the long term.
Finally, collaboration between research institutions and veterinarians plays an important role in combating HCM. By combining clinical practice and scientific research, new findings can be integrated more quickly into daily veterinary care, which could lead to better treatment outcomes for dogs with HCM.
The future of HCM research in dogs looks promising. With ongoing studies and advances in veterinary medicine, scientists hope to develop more effective diagnostic and treatment methods soon, significantly improving the lives of affected dogs.